The Vigabatrin REMS Program is required by the FDA to ensure educated risk-benefit choices before launching treatment, and to make certain appropriate use of vigabatrin while patients are treated. When vision loss will certainly occur, it is not feasible for your medical care service provider to know.
The most typical negative effects of SABRIL in children 3 to 16 years is weight gain. With severe vision loss, you may just be able to see things straight in front of you (occasionally called tunnel vision"). You go to danger for vision loss with any kind of amount of SABRIL.
If you are expecting or mean to get pregnant, tell your healthcare carrier. If vision testing can not be done, your healthcare provider may continue recommending SABRIL, but will not have the ability to look for any kind of vision loss. If vision tests are refrained on a regular basis, your healthcare provider may quit recommending SABRIL for you (or your child).